A new terrein glucoside, a novel inhibitor of angiogenin secretion in tumor angiogenesis. (Q39942286)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18776656%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

title

A new terrein glucoside, a novel inhibitor of angiogenin secretion in tumor angiogenesis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18776656%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

1 reference

(4S,5R)-5-[(α-D-glucopyranosyl) oxy]-4-hydroxy-3-(E-1-propenyl)-2-cyclopenten-1-one

1 reference

1 reference

(4S,5R)-5-[(alpha-D-glucopyranosyl) oxy]-4-hydroxy-3-(E-1-propenyl)-2-cyclopenten-1-one

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18776656%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

author name string

Masayuki Arakawa

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18776656%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Tetsuya Someno

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18776656%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Daishiro Ikeda

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18776656%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

publication date

1 July 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18776656%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

13 January 2020

https://www.nature.com/articles/ja200860.pdf

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.1038/ja.2008.60?email=unpaywall_01@example.com

published in

The Journal of Antibiotics

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18776656%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

volume

61

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18776656%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18776656%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

page(s)

442-448

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18776656%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.1038/ja.2008.60?email=unpaywall_01@example.com

access restriction status

open access

1 reference

inferred from online access status

exact match

https://scigraph.springernature.com/pub.10.1038/ja.2008.60

0 references

cites work

Role of angiogenesis in tumor growth and metastasis

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.60

Studies in the biochemistry of micro-organisms: The metabolic products of Aspergillus terreus Thom. A new mould metabolic product-terrein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.60

Tumorigenesis and the angiogenic switch

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.60

7 January 2021

VEGF and the quest for tumour angiogenesis factors

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.60

7 January 2021

Prostate cancer prevention by silibinin

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.60

7 January 2021

Green tea catechin, epigallocatechin-3-gallate, inhibits vascular endothelial growth factor angiogenic signaling by disrupting the formation of a receptor complex.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.60

7 January 2021

Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.60

7 January 2021

Characteristic ribonucleolytic activity of human angiogenin

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.60

7 January 2021

A therapeutic target for prostate cancer based on angiogenin-stimulated angiogenesis and cancer cell proliferation

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.60

7 January 2021

Significance of angiogenin plasma concentrations in patients with acute myeloid leukaemia and advanced myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.60

7 January 2021

Increased plasma levels of angiogenin and the risk of bladder carcinoma: from initiation ot recurrence

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.60

7 January 2021

Establishment of a highly tumorigenic LNCaP cell line having inflammatory cytokine resistance.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.60

7 January 2021

Highly tumorigenic human androgen receptor-positive prostate cancer cells overexpress angiogenin.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.60

7 January 2021

Mutarotase effect on colorimetric determination of blood glucose with β-D-glucose oxidase

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.60

7 January 2021

Production of Phenolic Compounds by Aspergillus S-4 in Sake Cake Medium and Identification of Terrein

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.60

7 January 2021

Terrein: a new melanogenesis inhibitor and its mechanism.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.60

7 January 2021

Terrein, a fungal metabolite, inhibits the epidermal proliferation of skin equivalents.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.60

7 January 2021

Endogenous angiogenin in endothelial cells is a general requirement for cell proliferation and angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.60

7 January 2021